Company Filing History:
2 out of 3 
1 out of 94 
Years Active: 2008-2011
Title: The Innovative Contributions of Pierre Guissou
Introduction
Pierre Guissou is a distinguished inventor based in Ouagadougou, Burkina Faso, recognized for his significant contributions to the field of pharmaceuticals. With a focus on innovative compounds aimed at treating cancer, particularly pancreatic cancer, Guissou has made notable strides in medical science.
Latest Patents
Guissou holds two patents that have the potential to revolutionize cancer treatment. His patents include "2″ oxo-voruscharin and derivatives thereof," which disclose compounds and pharmaceutical compositions useful in methods of treating cancer. Specifically, these compounds are beneficial in addressing pancreatic cancer, providing a hopeful avenue for patients suffering from this challenging illness. The second patent also relates to the "2″ oxo-voruscharin compound and its derivatives," emphasizing the importance of these compounds in pharmaceutical compositions aimed at cancer treatment.
Career Highlights
Throughout his career, Pierre Guissou has collaborated with reputable organizations, including Unibioscreen S.A. and Université Libre de Bruxelles. His work at these institutions has enabled him to contribute significantly to pharmaceutical research and development, particularly in oncology.
Collaborations
Guissou has worked alongside esteemed colleagues, including Eric Van Quaquebeke and Jean-Claude Braekman. Their combined expertise has fostered an environment ripe for innovation, enhancing the research and development processes necessary for creating effective cancer treatment alternatives.
Conclusion
Pierre Guissou's journey as an inventor reflects his commitment to advancing medical science through innovative research. His patents on 2″ oxo-voruscharin demonstrate his dedication to finding new solutions for critical health issues, specifically in the realm of cancer treatment. As he continues to work alongside established professionals in the field, Guissou's contributions are expected to make a lasting impact on the pharmaceutical industry.